| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |